| Feb 28, 2024 |
Feb 29, 2024 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-61,371
|
-5.29%
|
✗
|
$160.8K |
| Nov 16, 2023 |
Nov 17, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
95.0
|
+90,000
|
10.92%
|
✗
|
$94.8K |
| Nov 10, 2023 |
Nov 13, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
78.8
|
+10,000
|
1.23%
|
✗
|
$10.1K |
| Jun 29, 2023 |
Jun 29, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
78.8
|
+10,000
|
1.24%
|
✗
|
$21.6K |
| Jun 23, 2023 |
Jun 26, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
83.8
|
+20,000
|
2.55%
|
✗
|
$46.7K |
| Jun 22, 2023 |
Jun 22, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
90.0
|
+40,000
|
5.37%
|
✗
|
$92.4K |
| Feb 28, 2023 |
Mar 1, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-50,971
|
-6.41%
|
✗
|
$110.6K |
| Feb 28, 2022 |
Feb 28, 2022 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-48,053
|
-7.58%
|
✗
|
$137K |
| Feb 28, 2021 |
Mar 2, 2021 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
40.0
|
-55,038
|
-11.19%
|
✗
|
$395.7K |
| Feb 28, 2020 |
Mar 3, 2020 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-45,320
|
-13.17%
|
✗
|
$125.5K |
| Sep 18, 2019 |
Sep 19, 2019 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
95.0
|
+50,000
|
28.16%
|
✗
|
$155K |
| Sep 17, 2019 |
Sep 18, 2019 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
95.0
|
+50,000
|
39.20%
|
✗
|
$156.4K |
| Aug 16, 2019 |
Aug 20, 2019 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
95.0
|
+40,000
|
45.69%
|
✗
|
$54K |
| Feb 28, 2019 |
Mar 1, 2019 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-18,641
|
-17.56%
|
✗
|
$102.7K |
| Feb 28, 2018 |
Mar 2, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-9,494
|
-14.05%
|
✗
|
$81K |
| Nov 15, 2017 |
Nov 15, 2017 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
95.0
|
+10,000
|
30.32%
|
✗
|
$99.1K |
| Sep 15, 2017 |
Sep 18, 2017 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Buy |
97.5
|
+30,000
|
1005.03%
|
✗
|
$376.3K |
| Feb 28, 2017 |
Mar 1, 2017 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
42.5
|
-5,258
|
-20.20%
|
✗
|
$86.5K |
| Feb 29, 2016 |
Mar 2, 2016 |
LEXICON PHARMACEUTICALS, INC.
|
CEO |
Sell |
46.3
|
-4,036
|
-37.25%
|
✗
|
$36.6K |